Does Dupixent Cause Red Eyes?
Dupixent (dupilumab) lists eye-related issues, including conjunctivitis with redness, as common side effects. Clinical trials showed conjunctivitis in 10% of patients on Dupixent versus 2-4% on placebo, often presenting as red, itchy, or inflamed eyes.[1][2] The prescribing information notes "conjunctivitis" and "red eyes" explicitly under warnings, affecting up to 22% in some eczema studies.[3]
How Common Is It and Who Gets It Most?
Red eyes from Dupixent occur in about 5-20% of users, depending on the condition treated—higher in atopic dermatitis (up to 18%) than asthma or COPD.[1][4] It's more frequent in adults than children and often starts within weeks of treatment. Not everyone experiences it; many cases are mild and resolve without stopping the drug.[2]
What Do Patients Report About Red Eyes?
Real-world reports on forums and FDA data describe red eyes as burning, gritty, or bloodshot, sometimes with discharge. Some call it "Dupixent eyes." Severe cases (1-5%) lead to keratitis or blurred vision, prompting dose adjustments or eye drops.[3][5] Patient reviews on Drugs.com rate eye issues as a top complaint, with 10-15% mentioning redness.[6]
Why Does Dupixent Affect the Eyes?
Dupixent blocks IL-4 and IL-13, cytokines involved in inflammation. This can disrupt the eye's surface barrier (e.g., reduced goblet cells in conjunctiva), leading to dryness and redness. It's not an allergy to the drug but an off-target effect on ocular tissues.[2][4] Pre-existing dry eye or allergies raise risk.
How Is It Treated or Prevented?
Mild redness often improves with artificial tears or antihistamine drops. Doctors may prescribe steroid drops for inflammation or refer to ophthalmologists. About 80% of cases don't require stopping Dupixent.[3][7] Preventive steps include baseline eye exams and moisturizing eyes daily. If severe, pausing treatment resolves it quickly.
When Should You Worry About Red Eyes on Dupixent?
Contact a doctor if redness worsens, vision changes, pain increases, or light sensitivity develops—these signal possible infection or corneal damage (rare, <1%). It's not usually an emergency but needs monitoring.[1][3] Unlike infections, Dupixent-related redness lacks pus and responds to anti-inflammatories.
Alternatives If Eye Issues Persist
Switching to drugs like Eucrisa (crisaborole) or JAK inhibitors (e.g., Cibinqo) avoids IL-4/13 blockade, reducing eye risks. Biologics like Adbry (tralokinumab) have lower conjunctivitis rates (around 5%). Discuss with a dermatologist; no direct generic exists yet.[4][8]
[1]: Dupixent Prescribing Information (FDA), https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761055s050lbl.pdf
[2]: NEJM Study on Dupilumab (2016), https://www.nejm.org/doi/full/10.1056/NEJMoa1610020
[3]: Drugs.com Side Effects, https://www.drugs.com/sfx/dupixent-side-effects.html
[4]: Lancet Review on Dupilumab Ocular Effects (2020), https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30253-5/fulltext
[5]: FDA Adverse Event Reporting System (FAERS), https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard
[6]: Drugs.com Reviews, https://www.drugs.com/comments/dupilumab/dupixent.html
[7]: American Academy of Dermatology Guidelines, https://www.aad.org/practicecenter/quality/clinical-guidelines/atopic-dermatitis
[8]: DrugPatentWatch.com (Dupixent patents expire 2032+), https://www.drugpatentwatch.com/p/tradename/DUPIXENT